Literature DB >> 19643098

Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease.

Mohammed Filali1, Robert Lalonde.   

Abstract

A large series of 3-, 6-, 9-, and 12-month-old bigenic mice (N=240) with Swedish APP and A246E PS1 mutations was investigated in nest-building, spontaneous alternation, and two learning tasks. Progressive cognitive impairment was observed in APPswe/PS1 mice relative to controls for nest-building, spontaneous alternation, the reversal phase of left-right discrimination learning in a water-filled T-maze, and in retention of passive avoidance learning. The behavioral deficits in transgenic mice start at 6 months, appearing to offer an opportunity for assessing potential therapeutic agents in attenuating or preventing Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643098     DOI: 10.1016/j.brainres.2009.07.066

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  42 in total

1.  Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.

Authors:  Santiago V Salazar; Timothy O Cox; Suho Lee; A Harrison Brody; Annabel S Chyung; Laura T Haas; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2018-12-05       Impact factor: 6.167

Review 2.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

3.  Hematopoietic MyD88-adaptor protein acts as a natural defense mechanism for cognitive deficits in Alzheimer's disease.

Authors:  Jean-Philippe Michaud; Karine L Richard; Serge Rivest
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 4.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

5.  The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.

Authors:  Shenghua Zhu; Junhui Wang; Yanbo Zhang; Jue He; Jiming Kong; Jun-Feng Wang; Xin-Min Li
Journal:  CNS Neurosci Ther       Date:  2017-02-12       Impact factor: 5.243

6.  Adaptation of the Arizona Cognitive Task Battery for use with the Ts65Dn mouse model (Mus musculus) of Down syndrome.

Authors:  Michael R Hunsaker; Genevieve K Smith; Raymond P Kesner
Journal:  J Comp Psychol       Date:  2017-03-23       Impact factor: 2.231

7.  Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease.

Authors:  Santiago V Salazar; Christopher Gallardo; Adam C Kaufman; Charlotte S Herber; Laura T Haas; Sophie Robinson; Jean C Manson; Michael K Lee; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

8.  Xanthoceraside modulates NR2B-containing NMDA receptors at synapses and rescues learning-memory deficits in APP/PS1 transgenic mice.

Authors:  Lin Zhu; Lei Yang; Xuemei Zhao; Danyang Liu; Xiaoli Guo; Peng Liu; Tianyan Chi; Xuefei Ji; Libo Zou
Journal:  Psychopharmacology (Berl)       Date:  2017-11-09       Impact factor: 4.530

9.  Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.

Authors:  Qiaoqiao Shi; Saba Chowdhury; Rong Ma; Kevin X Le; Soyon Hong; Barbara J Caldarone; Beth Stevens; Cynthia A Lemere
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

10.  Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia.

Authors:  Jonathan L Brigman; Carolyn Graybeal; Andrew Holmes
Journal:  Front Neurosci       Date:  2010-05-15       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.